tirzepatide serena williams is returning to tennis — and bringing the GLP-1 debate with her Serena Williams is opening up

It appeals to patients who dislike needles

Common eligibility criteria may include: BMI of 30 or higher BMI of 27 or higher with at least one weight-related health condition History of failed diet attempts or weight regain Appetite, cravings, or portion control challenges Metabolic risk factors such as insulin resistance, elevated glucose, high cholesterol, or hypertension Need for physician-supervised weight loss due to medical complexity Eligibility must be determined through a medical consultation

Weight loss follows a more gradual trajectory

Since it was deemed unethical to treat people with established cardiovascular disease (CVD) and type 2 diabetes (who are at high risk of future cardiovascular events) with placebo, the present study, SURPASS-CVOT, was the first cardiovascular outcomes trial to use an active comparator: in this case, dulaglutide 1.5 mg weekly, which had previously been proven to have cardiovascular benefit in the REWIND trial (Gerstein et al, 2019)

Here at EOWC, we use high-quality products to help assist many of our patients with their weight

But smaller volumes are harder to measure accurately on an insulin syringe